Radiomic prediction for durable response to high‐dose methotrexate‐based chemotherapy in primary central nervous system lymphoma
Abstract Background The rarity of primary central nervous system lymphoma (PCNSL) and treatment heterogeneity contributes to a lack of prognostic models for evaluating posttreatment remission. This study aimed to develop and validate radiomic‐based models to predict the durable response (DR) to high...
Saved in:
| Main Authors: | Haoyi Li, Mingming Xiong, Ming Li, Caixia Sun, Dao Zheng, Leilei Yuan, Qian Chen, Song Lin, Zhenyu Liu, Xiaohui Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of primary central nervous system lymphomas
by: I. V. Cherkashina, et al.
Published: (2021-06-01) -
Population pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma
by: Shifeng Wei, et al.
Published: (2025-05-01) -
Early toxicity of high-dose methotrexate in the treatment of non-hodgkin lymphomas in children
by: Z. K. Simavonyan, et al.
Published: (2025-03-01) -
Radiomics model building from multiparametric MRI to predict Ki-67 expression in patients with primary central nervous system lymphomas: a multicenter study
by: Yelong Shen, et al.
Published: (2025-02-01) -
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma
by: Chuanwei Yang, et al.
Published: (2025-02-01)